These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11503532)
41. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657 [TBL] [Abstract][Full Text] [Related]
43. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture? Groh KW; Stevermer JJ J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004 [No Abstract] [Full Text] [Related]
44. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response. Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896 [TBL] [Abstract][Full Text] [Related]
45. [Hormone substitution by injectable preparations and skin implants]. Kuhl H Gynakologe; 1986 Dec; 19(4):241-7. PubMed ID: 3817596 [No Abstract] [Full Text] [Related]
46. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213 [TBL] [Abstract][Full Text] [Related]
47. A clinician's review of the WHI-related literature. Speroff L Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264 [TBL] [Abstract][Full Text] [Related]
48. Cardiovascular effects of estrogen replacement therapy. Chae CU; Manson JE Adv Intern Med; 2001; 47():47-88. PubMed ID: 11795080 [No Abstract] [Full Text] [Related]
49. [Climacteric--from the viewpoint of the established gynecologist. Interview by Jeanette Gerhardt]. Gericke DS Geburtshilfe Frauenheilkd; 1994 Jan; 54(1):IX-X. PubMed ID: 8150240 [No Abstract] [Full Text] [Related]
50. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension. Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486 [TBL] [Abstract][Full Text] [Related]
51. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects]. Gregersen N; Hilmand CB; Jensen PT; Giraldi AG Ugeskr Laeger; 2006 Feb; 168(6):559-63. PubMed ID: 16476214 [TBL] [Abstract][Full Text] [Related]